कोशिश गोल्ड - मुक्त
India, critical player in global laboratory equipment scene
Chronicle Pharmabiz
|October 16, 2025
THE vibrant Indian laboratory equipment and analytical instruments market is poised for significant growth, fuelled by rising investments in research and development (R&D), contract research projects and increasing demand for advanced laboratory techniques.
The sector is further propelled by innovation and strategic collaborations. The rising startup activity and increased foreign direct investment in lab equipment and analytical instrumentation, position India as a critical player in the space.
According to a market report, laboratory equipment services market size is estimated to reach $22.1 billion by 2027, growing at a CAGR of 11.1 per cent during the forecast period 2022-2027 with the Asia-Pacific region expected to be the highest contributor to this growth.
The big names in the lab market in India investing in R&D include Agilent Technologies; Thermo Fisher Scientific Inc.; Waters Corporation; Danaher Corporation; Merck Eppendorf AG; PerkinElmer Inc; Pace Analytical Services Inc.
The age of automation
In an age of Industry 4.0 automation, robotics, Internet of Things (IoT), Artificial Intelligence (AI), Machine Learning (ML) and advanced imaging techniques are signalling a shift in investment priorities. Advances in imaging technologies, like high-resolution microscopy and imaging software allow for detailed and accurate analysis in research and diagnostics. 3D Printing technology helps develop custom lab equipment and prototypes, allowing for rapid development and testing of new devices.
No doubt technology infusion is streamlining laboratory processes, increasing efficiency, and decreasing human error in sample analysis and data collection. AI and ML are enabling advanced data analysis, predictive maintenance, and personalized medicine, allowing for more accurate and faster results. Further, IoT-enabled devices are improving connectivity between lab instruments, facilitating real-time monitoring and data sharing, which speeds up decision-making.
यह कहानी Chronicle Pharmabiz के October 16, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Chronicle Pharmabiz से और कहानियाँ
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
